Virtual cell models that enable the prediction of cell behavior across scales and biological contexts are rapidly emerging at the forefront of drug discovery. Tom Sercu, PhD, vice president of AI and ...

RyboDyn, Inc., a biotechnology company decoding the dark proteome with an AI-powered sequencing and discovery platform, today announced a $1.3 million award from the U.S. Department of War (DOW) to ...

Hattie Chung, PhD, began her journey to becoming a scientist at the age of eight when she moved from Seoul, South Korea, to ...

Multiomics data integration with machine learning has become the standard approach for combining genomic, transcriptomic, proteomic, and metabolomic measurements collected from the same biological ...

A new study generated one of the most comprehensive spatially resolved transcriptomic maps of cellular communication between ...

The obsession with flawless muscle definition and rapid weight loss has taken over Indian fitness culture. From shaker ...

New data just threw a spicy curveball: natural compounds found in garlic extended lifespan by nearly twice as much as ...

Biomedical engineer Sangeeta Bhatia reflects on her journey in pioneering liver research, developing advanced diagnostics, ...

Study finds obesity drives breast cancer invasion through a unique molecular pathway, separate from known risk factors.

The molecular machinery that normally builds proteins inside cells has now taken on a new role as a "switch." A research team ...